Advertisement Case #3 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about IQnovate

Case #3

CASE STUDIES
By IQnovate

Customer wants to revitalize lifecycle of prescription mature product which was leader in antihistamines.

Critical Issues

No A&P allocated on mature products, no sales support

The commercial solution

We propose to down schedule from prescription medicine to OTC

Results

We compiled the down schedule dossier with our medical affairs, regulatory and market access team. Submitted to regulatory authorities. Down schedule accomplished. Product sales increased by 63% within 4 months

Quick Contact